Trial Profile
Evaluation of the effects of MC-1 [pyridoxal phosphate] alone and in combination with an ACE inhibitor on ambulatory blood pressure and metabolic function in hypertensive patients with type 2 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Lisinopril (Primary) ; Pyridoxal phosphate (Primary)
- Indications Hypertension; Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms MATCHED
- Sponsors Medicure
- 16 Apr 2008 Interim results were reported at ATVB 2008, according to a Medicure media release.
- 23 Aug 2007 The expected completion date for this trial is now 1 Jul 2005.
- 30 Dec 2005 New trial record.